"Innovation is found where people, ideas
and technologies intersect."

Patrick Verheyen, Head J&J London Innovation Center

"We need to join forces if we want to solve
Alzheimer's Disease."

Bart De Strooper, Professor at VIB and KU Leuven, Co-director LIND

Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic lateral sclerosis (ALS), also called Lou Gehrig's disease, is a rapidly progressive, invariably fatal neurodegenerative disease that attacks the neurons that control voluntary muscles. This leads to the weakening, atrophy and twitching of muscles and eventually to total loss of the ability to start and control voluntary movement. When muscles in the diaphragm and chest wall fail, patients lose the ability to breathe without ventilator support. Most people with ALS die from respiratory failure, usually within three to five years from the onset of symptoms. About 10 percent survive for 10 years or more.(1)